| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.74B | -4.5% |
| Cost of Revenue | $9.12B | +1.4% |
| Gross Profit | $5.62B | -12.7% |
| R&D Expense | $808.7M | +0.4% |
| SG&A Expense | $4.43B | -4.8% |
| Operating Income | $10.1M | -98.7% |
| Interest Expense | $550.0M | -4.0% |
| Pre-tax Income | -$623.2M | -407.1% |
| Income Tax | $11.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $734.8M | -25.9% |
| Accounts Receivable | $3.22B | -12.9% |
| Inventory | $3.85B | +11.1% |
| Current Assets | $9.52B | -26.6% |
| Total Assets | $41.50B | -13.0% |
| Current Liabilities | $5.78B | -25.7% |
| Long-term Debt | $14.04B | -13.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.30B | -17.7% |
| Capital Expenditures | $326.0M | -13.5% |
| Investing Cash Flow | $1.80B | +335.7% |
| Financing Cash Flow | -$4.33B | -88.1% |
| Free Cash Flow | $1.98B | -18.4% |
| -92.6% |
| Net Income | -$634.2M | -1259.4% |
| EPS (Basic) | -$0.53 | -1160.0% |
| EPS (Diluted) | -$0.53 | -1160.0% |
| Total Liabilities |
| $22.87B |
| -16.0% |
| Stockholders' Equity | $18.64B | -9.0% |